Tag - pharmaceuticals

 
Menu
Search
 
July 16, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS

Japan Times
BUSINESS
Apr 27, 2020
Shionogi to develop coronavirus vaccine, with trials eyed for this year
Shionogi & Co. said Monday it will develop a vaccine for the novel coronavirus with the aim of starting clinical trials this year.
Japan Times
WORLD / Science & Health
Apr 26, 2020
Countries and companies risk billions in race for coronavirus vaccine
Governments, charities and Big Pharma firms are making huge bets with extraordinarily low odds of success.
Japan Times
WORLD
Apr 23, 2020
Official says he was ousted for urging caution on Trump-touted virus drug
The ousted director of a key U.S. agency charged with developing drugs to fight the COVID-19 pandemic said Wednesday he was dismissed because he called for careful vetting of a treatment frequently touted by President Donald Trump.
Japan Times
JAPAN / FOCUS
Apr 23, 2020
Abe touts Avigan as COVID-19 treatment despite experts urging caution
Medical experts warn the drug, also known as favipiravir, may cause birth defects and it cannot be administered to expecting mothers or those who may become pregnant.
Japan Times
WORLD / Science & Health
Apr 22, 2020
Hydroxychloroquine, championed by Trump for virus, may raise death risk
An old malaria drug touted by U.S. President Donald Trump as a "game changer" in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that has been submitted for expert review.
Japan Times
BUSINESS / Companies
Apr 15, 2020
Fujifilm to boost capacity to make COVID-19 treatment Avigan
Fujifilm Holdings Corp. said Wednesday it has expanded manufacturing capacity to "significantly increase" production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19.
Japan Times
WORLD / Science & Health
Apr 14, 2020
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply
Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said.
Japan Times
ASIA PACIFIC / Science & Health
Apr 7, 2020
After Trump threat, India lifts export ban on COVID-19 treatment drug
India has partially lifted a ban on the exports of a malaria drug after U.S. President Donald Trump sought supplies for the United States, according to government officials with knowledge of the matter.
Japan Times
JAPAN / Science & Health
Apr 7, 2020
Japan to offer anti-flu Avigan drug to 20 virus-hit nations for free
Japan plans to provide the anti-flu drug Avigan for free to 20 countries hoping to use it to treat coronavirus patients, Foreign Minister Toshimitsu Motegi said Tuesday.
Japan Times
WORLD / Science & Health / FOCUS
Apr 6, 2020
Fast-moving virus pits treating patients against finding a cure
Pharmaceutical research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't.
Japan Times
JAPAN / Science & Health
Apr 5, 2020
Japan to boost Avigan drug stockpile as part of coronavirus stimulus
Japan is considering increasing the stockpile of Fujifilm Holding Corp.'s Avigan anti-flu drug during this fiscal year so it can be used to treat 2 million people.
Japan Times
BUSINESS / Companies
Mar 31, 2020
Firms sign deals with U.S. to prep for mass-producing virus vaccines
The U.S. government has cut deals with Johnson & Johnson and Moderna Inc. and said it is in talks with at least two other companies to prepare them to produce massive quantities of coronavirus vaccines even before safe and effective ones become available.
JAPAN / Science & Health
Mar 24, 2020
Japan to join trial to test Ebola drug on COVID-19 patients
The National Center for Global Health and Medicine (NCGM) said Monday that it will join an international clinical trial on the use of remdesivir, which is being developed as a remedy for Ebola, to treat people infected with the new coronavirus.
Japan Times
JAPAN / Science & Health
Mar 19, 2020
Japanese researchers to test blood thinner for coronavirus treatment
A blood thinner used to treat pancreatitis and kidney disease has been identified as a potential therapy for COVID-19 patients, with clinical trials in Japan possibly set to begin within a month, researchers at the University of Tokyo said Wednesday.
Japan Times
WORLD / Science & Health
Mar 19, 2020
HIV drug combo fails as treatment for severe COVID-19 in China study
A pill containing two HIV drugs that was touted as a potential treatment for the novel coronavirus was not effective, according to a study released late on Wednesday in the New England Journal of Medicine.
Japan Times
BUSINESS
Mar 4, 2020
Japan's largest drugmaker working to develop virus treatment, Dow Jones reports
Takeda Pharmaceutical Co. is developing an experimental therapy for the novel coronavirus with the goal of making it available in 9 to 18 months, the nation's largest drugmaker said.
Japan Times
JAPAN / Science & Health
Feb 26, 2020
Japanese government panel OKs expensive gene therapy for rare disease
A health ministry panel approved the production and sales of a gene therapy for treating spinal muscular atrophy, a rare incurable disease that destroys muscle function.
BUSINESS
Feb 26, 2020
U.S. begins first coronavirus clinical trial testing Gilead's experimental drug
U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.'s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
Japan Times
BUSINESS
Feb 24, 2020
Boris Johnson to begin trade talks with U.S. in two weeks, Telegraph reports
British Prime Minister Boris Johnson is prepared to begin trade talks with the United States within the coming two weeks, the Telegraph reported on Sunday.
JAPAN / Science & Health
Feb 22, 2020
Tosoh working on chemical reagent that could slash COVID-19 detection times
Chemical maker Tosoh Corp. said it has begun developing a reagent that can detect the new coronavirus in less than 50 minutes, slashing the six-hour waiting time required by current test kits.
Who needs AI when you have Hatsune Miku?
Over the first six months of 2024, a handful of songs using Vocaloid singer Hatsune Miku’s voice have enjoyed widespread attention, underlining a global interest in the character and the technology she represents.
Bloodied Trump survives assassination attempt at political rally
Former U.S. President Donald Trump is surrounded and evacuated by Secret Service agents at a campaign rally in Butler, Pennsylvania, on Saturday. Trump was rushed off stage at the rally after shots rang out.
Shooter came within inches of killing Trump, but left few clues as to why
An aerial view shows the stage where Republican presidential candidate and former U.S. President Donald Trump had been standing during an assassination attempt the day before, and the roof of a nearby building where a gunman was shot dead by law enforcement, in Butler, Pennsylvania, on Sunday.
Yen’s woes seem too big for even a BOJ hike this month to solve
The Bank of Japan headquarters in Tokyo
How to beat Japan’s summer heat in ways better for the planet
Tenugui towels hang up to dry at a dyeing company in Sakai, Osaka Prefecture, on May 8. The durable and versatile tenugui, which many people have in their homes, can be used in many ways to cool one’s body.
The neurological disorder that 'kills culture'
Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
How to beat Japan’s summer heat in ways better for the planet
Tenugui towels hang up to dry at a dyeing company in Sakai, Osaka Prefecture, on May 8. The durable and versatile tenugui, which many people have in their homes, can be used in many ways to cool one’s body.
After Trump shooting, U.S. presidential race might take a violent turn
United States Secret Service Counter Snipers stand guard on a rooftop during a campaign rally for U.S. President Donald Trump in Avoca, Pennsylvania, in 2020.
No AC this summer? No problem (for me).
Think air conditioning is a requirement for a Tokyo summer? Think again.
She’s paying ¥1 million to help behind the scenes at the Paris Olympics
Mai Tarumi, who previously volunteered at the postponed Tokyo Olympics in 2021, has a travel budget of ¥1 million for her trip to volunteer at the Paris Games.

Podcast

You can often see generations of families enjoying performances together at Fuji Rock Festival.
Japan’s summer music festivals are feeling the heat in more ways than one

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'
By Tomoko Otake

SUSTAINABLE JAPAN

Omron helping firms achieve carbon neutrality
Omron helping firms achieve carbon neutrality

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER